Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Diabetes care - 1 Feb 2010

Pal Aparna, Farmer Andrew J, Dudley Christina, Selwood Mary P, Barrow Beryl A, Klyne Rhiannon, Grew Jilly P, McCarthy Mark I, Gloyn Anna L, Owen Katharine R

Abstract excerpt

OBJECTIVE: Assignment of the correct molecular diagnosis in diabetes is necessary for informed decisions regarding treatment and prognosis. Better clinical markers would facilitate discrimination and prioritization for genetic testing between diabetes subtypes. Serum 1,5 anhydroglucitol (1,5AG) levels were reported to differentiate maturity-onset diabetes of the young due to HNF1A mutations (HNF1A-MODY) from type...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Creatinine
Share to Deoxyglucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucokinase

Share to Glucose Tolerance Test

Share to Glycated Hemoglobin

Share to Hepatocyte Nuclear Factor 1-alpha

Share to Insulin-Secreting Cells

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 19933992
DOI: 10.2337/dc09-1246
PMCID: PMC2809258

Genes

GCK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.PMID 19933992Read ↗

Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.Semantic proximity Read ↗

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.Semantic proximity Read ↗

Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.Semantic proximity Read ↗

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.Semantic proximity Read ↗

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.Semantic proximity Read ↗

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.Semantic proximity Read ↗

Clinical and genetic characterization and long-term evaluation of individuals with maturity-onset diabetes of the young (MODY): The journey towards appropriate treatment.Semantic proximity Read ↗

Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune DiabetesSemantic proximity Read ↗

Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young.Semantic proximity Read ↗

Machine Learning for Interpretation of DNA Variants of Maturity-Onset Diabetes of the Young Genes Based on ACMG CriteriaSemantic proximity Read ↗

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.Semantic proximity Read ↗

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.